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1. Introduction 
Preterm infants, especially the extremely preterm, require a large amount of support ex 
utero. They are often critically ill with greatly reduced chances of survival. Many die because 
of their overall immaturity with multiple organ systems that cannot adjust to extrauterine 
life, especially the lungs. Many die from their primary lung disease. The respiratory support 
they get from positive pressure ventilation almost always causes significant secondary lung 
injury.  
Over the previous decades partial liquid ventilation has been put forward as an adjunct form 
of respiratory support for especially immature lungs and severe lung disease: not only to 
provide a superior form of respiratory support but to deliver that support with reduced lung 
injury. Recent studies have renewed the hope that partial liquid ventilation has great potential 
to change the course of neonatal lung disease and respiratory morbidity. (Blassnig, 2009) 
Unfortunately, the extremely preterm infant is also at great risk of particular forms of brain 
injury (e.g., intraventricular haemorrhage, periventricular leucomalacia and other white 
matter injury). Disturbance of cerebral blood flow has been demonstrated to considerably 
increase the risk of these forms of brain injury. 
One of the concerns with using partial liquid ventilation in the extremely preterm infant is 
its affect on cerebral blood flow which could lead to brain injury, especially at the start of 
partial liquid ventilation during the initial dosing of perfluorocarbon into the lungs. Any 
benefits of partial liquid ventilation might be outweighed by an increased risk of brain 
injury and the subsequent devastating consequences.  
Before using partial liquid ventilation in human preterm infants it should be known to be 
safe with regard to its effects on cerebral blood flow during perfluorocarbon dosing. The 
effect of perfluorocarbon dosing at the start of partial liquid ventilation on cerebral blood 
flow can be mitigated to minimise or eliminate these adverse effects. 
2. The consequences of lung disease in the extremely preterm neonate 
2.1 Mortality 
The extremely preterm infant, born at less than 26 weeks gestational age, is at great risk of 
dying. The risk increases with decreasing gestational age. The majority of these infants die 
because of general immaturity (including extremely immature lungs) or lung disease. 
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Data are available from Australia and New Zealand. All babies that are admitted to a 
newborn nursery who were born at less than 32 completed weeks gestation, or weighed 
<1,500 grams at birth, or received assisted ventilation (mechanical ventilation), or received 
major surgery are registered with the Australian and New Zealand Neonatal Network 
(ANZNN). The ANZNN reports annually on all registered babies. (ANZNN, 2009)  The 
latest report of the ANZNN (ANZNN, 2009) is for births in 2006; of 339,271 live births there 
were 7,592 registered babies (2.2% of live births). There were 412 registered babies born at 
<26 weeks gestational age (5.4% of registered babies). Two thirds (276/412) survived to be 
discharged home – a mortality of 33%.  
The EPICure study (Wood, 2000) is a large population based study designed to reveal 
outcomes for extremely preterm infants. They enrolled all babies born at less than 26 weeks 
gestational age, from March 1995 to December 1995, who were admitted to a neonatal 
intensive care unit in the United Kingdom of Great Britain and Northern Ireland and the 
Republic of Ireland. These infants are deemed to be extremely immature and at the limits of 
viability. About sixty percent (60%) of these infants died before discharge from hospital and 
about 70% of those deaths had a respiratory cause. (Costeloe, 2000) In an Australian study 
from around the same period (1992-1996) at the Royal Women’s Hospital in Melbourne, 
about 28% of live born infants of 23 to 27 weeks gestational age died. Of those infants 
admitted to the intensive care nursery 60% of deaths had a respiratory cause. (Doyle, 1999) 
Recent data are available from the Royal Brisbane and Women's Hospital in Brisbane, 
Australia. From 2003-2007 inclusive there were 163 infants admitted of  less than 26 weeks 
gestational age: 58 (36%) died. Sixty-two percent (62%) of those deaths were either due to 
‘extreme prematurity’ or a direct respiratory cause. (Cartwright, 2003; Cartwright, 2004; 
Cartwright, 2005; Cartwright, 2006; Cartwright, 2007)  
2.2 Respiratory morbidity 
Lung immaturity and/or lung disease not only carries a high mortality in extremely 
preterm babies, but it also causes significant morbidity. This includes the requirement for 
respiratory support, air leak and neonatal chronic lung disease. Mechanical ventilation often 
causes significant secondary lung injury due to barotrauma and volutrauma. This makes the 
acute lung disease much worse and, along with extreme prematurity, is a major factor in the 
subsequent progression to chronic lung disease. Neonatal chronic lung disease consists of 
distortion of the lung architecture, disturbed lung growth and chronic inflammation of the 
small airways and the lung parenchyma. Most patients with neonatal chronic lung disease 
are born extremely preterm. Infants with chronic lung disease have significant morbidity 
which manifests as a requirement for prolonged respiratory support and oxygen therapy, as 
well as an increased hospital stay. Chronic lung disease is also a major cause of late 
mortality.  
Many extremely preterm infants need mechanical ventilation. About ninety percent (90%) of 
ANZNN registered babies in 2006 required some form of assisted ventilation. (ANZNN, 
2009) The mean length of time of assisted ventilation was 11 days. Most babies required 
respiratory support for either hyaline membrane disease or non-specific respiratory distress. 
Intubation and positive pressure mechanical ventilation was required by ninety-seven 
percent (97%) of babies born <26 weeks gestation. The most extreme form of acute  
lung injury in ventilated neonates is air leak (pneumothorax, pulmonary interstitial 




Partial Liquid Ventilation in the Extremely Preterm Infant: Potential Benefits and Harms 
 
507 
The ANZNN defines chronic lung disease as any registered baby born less than 32 weeks 
gestational age who needs assisted ventilation for their initial lung disease and continues to 
require some form of respiratory support or oxygen therapy at 36 weeks corrected 
gestational age. Of babies born less than 26 weeks gestational age, who survived to 36 weeks 
corrected gestational age, 55% had chronic lung disease. Four percent (4%) of surviving 
registered babies born less than 32 weeks gestational age required prolonged oxygen 
therapy and went home on oxygen treatment. (ANZNN, 2009) 
Local data from the Royal Brisbane and Women's Hospital (Cartwright, 2003; Cartwright, 
2004; Cartwright, 2005; Cartwright, 2006; Cartwright, 2007) from 2003 to 2007 inclusive for 
163 infants admitted of less than 26 weeks gestational age showed that: 
 99% were intubated and ventilated; 
 the mean length of time of ventilation was 36 days (2001-2007 data only); 
 27% had an air leak; 
 74% had chronic lung disease; and 
 16% went home on oxygen treatment. 
Three quarters (74%) of the EPICure cohort (Hennessy, 2008) had moderate to severe 
chronic lung disease; 36% went home on oxygen treatment. By two years of age almost two 
thirds of the cohort required hospital admission at least once for a respiratory illness. At six 
years many of the cohort had continuing respiratory symptoms, abnormal respiratory 
findings on physical examination and/or abnormal respiratory function tests. 
2.3 Non-respiratory morbidity 
Non-respiratory morbidity is very common in extremely preterm infants. This includes a 
number of different organ systems. The major morbidities include patent ductus arteriosus, 
necrotising enterocolitis, retinopathy of prematurity, intraventricular haemorrhage and 
periventricular leucomalacia.  
Extremely preterm infants that survive also require a prolonged hospital stay (even when 
this is not because of respiratory disease). The long-term sequelae of extreme prematurity 
can include adverse neurodevelopmental outcomes such as developmental delay, cognitive 
and learning impairment, cerebral palsy, blindness and deafness. 
Local data from the Royal Brisbane and Women’s Hospital from 2003 to 2007 inclusive 
(Cartwright, 2003; Cartwright, 2004; Cartwright, 2005; Cartwright, 2006; Cartwright, 2007) 
shows that of the 163 infants admitted of less than 26 weeks gestational age: 
 61% had a patent ductus arteriosus; 
 46% had an intraventricular haemorrhage and/or periventricular leucomalacia; 
 16% had a severe intraventricular haemorrhage; 
 57% had retinopathy of prematurity (20% had severe retinopathy of prematurity); and 
 the average length of stay in hospital was 127 days. 
2.4 Mechanical ventilation 
The management of lung disease in extreme preterm infants is predicate on the principle 
that respiratory support be provided until there is sufficient resolution of the lung disease 
and respiratory support is no longer required. Mechanical ventilation is a means of 
providing such support for babies with severe lung disease or extreme prematurity. 
Ventilation is provided to support gas exchange, i.e., oxygenation and carbon dioxide 
clearance.   
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The types of mechanical ventilation include- 
1. Conventional mechanical ventilation – pressure controlled, time-cycled ventilation, 
including: 
 intermittent positive pressure ventilation; 
 synchronised intermittent positive pressure ventilation; 
 volume-targeted ventilation. 
2. High frequency ventilation. 
3. Volume-controlled ventilation – rarely used in neonates. 
As can be seen from the above data the more usual forms of mechanical ventilation often 
don’t work (babies still die from their extremely immature lungs and lung disease) and 
often damage the lungs causing significant respiratory morbidity (lung injury and 
subsequent chronic lung disease). 
There is still a need for alternative forms of respiratory support that can provide ventilation 
and adequate gas exchange without damaging the lungs or put the infant at increased risk 
of brain injury.  
3. The risk of brain injury in the extremely preterm infant  
The developing brain is especially prone to injury and extremely preterm infants are at 
significant risk; this can result in long-term disability. (Vohr, 1996) The most common forms 
of brain injury arising in preterm infants are intraventricular haemorrhage, periventricular 
leukomalacia and other forms of white matter injury. Disturbance of cerebral blood flow 
have been demonstrated to substantially increase the risk of brain injury. 
The germinal matrix lies in the subependymal region at the floor of the lateral ventricle and 
this is the site of intraventricular haemorrhage. It is especially prone to both under perfusion 
and over perfusion. The vascular structure of this region predisposes to damage from 
ischaemia and later reperfusion and/or over perfusion with subsequent venous 
haemorrhage. (Takashima, 2009) With severe grades of intraventricular haemorrhage there 
is additional haemorrhage in the periventricular white matter; both focal injury and more 
diffuse white matter injury. The white matter is especially susceptible because of the 
vulnerability of the glia (especially premyelinating oligodendrocytes) which is gestational 
age dependant. Also the periventricular area has a blood supply which is immature and 
watershed. The white matter is also particularly prone to hypoperfusion. (Takashima, 2009; 
Volpe, 2009a; Volpe, 2009b) 
Given the vulnerability of the brain of the extremely preterm infant to both under and over 
perfusion it is not surprising that fluctuations of cerebral blood flow cause the most overt 
types of brain injury. (Ballabh, 2010; Perlman, 2009) Factors that lead to low cerebral blood 
flow also increase the risk of intraventricular haemorrhage and similarly those factors that 
lead to increased cerebral blood flow also increaese the risk of intraventricular haemorrhage. 
(Bassan, 2006) Periventricular leucomalacia can be easily produced in animal models of 
cerebral ischaemia. (Yoshioka, 1994; Ohyua, 1999) 
Increased cerebral blood flow velocity increases the incidence of intraventricular 
haemorrhage and extension of existing intraventricular haemorrhage. (Van Bel, 1987) Low 
cerebral blood flow states increase the risk of intraventricular haemorrhage. (Kluckow 2000;  
du Plessis, 2008) The strongest link exists with the development of intraventricular 
haemorrhage and more variability in cerebral blood flow. (Vohr, 1996; Van Bel,  1987; 
Mullaart; 1994, Kissack, 2004; Perlman, 1983; Takashima 1995) In the beagle pup model 
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rapid changes in cerebral perfusion easily produce subependymal haemorrhages 
indistinguishable from those seen in human preterm infants. (Ment, 1982) Keeping cerebral 
blood flow fluctuations to a minimum must be a prime aim when caring for extremely 
preterm infants to prevent intraventricular haemorrhage. (du Plessis, 2008; Wells, 1995) 
There are many factors that are known to alter cerebral blood flow in newborn infants (see 
Table 1). Because the preterm infant is more likely to have all the conditions listed in the left 
hand column of Table 1 it is not unreasonable to presume that fluctuations in cerebral blood 
flow are common particularly in the first few days of life. The preterm infant may also 
experience wide variations in cerebral blood flow because they do not have the normal 
autoregulation of cerebral blood flow. Thus periods of pressure-passive cerebral circulation 
are likely; the fluctuations in blood pressure that are common (Coughtrey, 1997) expose 
them to the extremes of cerebral blood flow and put them at risk of intraventricular 
haemorrhage. (du Plessis, 2008) 
 
Factor Effect 
Cerebral perfusion pressure 
 
- arterial BP 
 
- venous pressure 
increased perfusion pressure  increases CBF    
     … and vice versa 
- increased arterial pressure  increases CBF    
     … and vice versa 
- decreased venous pressure  increases CBF    
     … and vice versa 
PaCO2  increased PaCO2  increases CBF   … and vice versa 
PaO2 increased PaO2  increases CBF   … and vice versa 
Patent ductus arteriosus PDA with Left-to-Right shunt  decreases diastolic flow  
which  decreases CBF 
Hypoglycaemia decreased blood glucose  increases CBF 
Haemoglobin/blood viscosity increased viscosity  decreases CBF   … and vice versa 
Posthypoxic-ischaemic injury vaso-dilatation  increases CBF 
Brain metabolism/activity increased activity increases CBF   … and vice versa 
Autonomic nervous system increased parasympathetic drive  increases CBF   … 
and vice versa 
decreased sympathetic drive  increases CBF   … and 
vice versa 
Temperature mild-moderate hyperthermia  increases CBF 
hypothermia decreases CBF 
Table 1. Factors known to alter cerebral blood flow. (Perlman, 2009; Pryds, 1996; Ito, 2005; 
Vavilala, 2002; Greisen, 2005; Volpe, 1982; Leahy, 1980; Rahilly, 1980) (CBF – cerebral blood 
flow; BP – blood pressure; CVP – central venous pressure; PaCO2 – arterial carbon dioxide; 
PaO2 – arterial oxygen; PDA – patent ductus arteriosus) 
Many of the mechanisms listed in Table 1 put the extremely preterm infant at serious risk of 
significant cerebral blood flow alterations and intraventricular haemorrhage. Many 
respiratory problems or treatments are known to alter cerebral blood flow and/or increase 
the risk of intraventricular haemorrhage. These include: 
 intratracheal surfactant instillation (has been shown to increase or decrease cerebral 
blood flow velocity on Doppler ultrasound (Schipper, 1997; Saliba, 1994; Kaiser, 2004); 
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 asynchronous breathing mechanical ventilation (increases the variability of cerebral 
blood flow (Rennie, 1987); 
 endotracheal tube suction (has been shown to increase or decrease cerebral blood flow 
on near infrared spectroscopy (Limperopoulos, 2008;, Perlman, 1983; Kohlhauser, 2000); 
 endotracheal tube retaping increases cerebral blood flow on near infrared spectroscopy 
(Limperopoulos, 2008); 
 pneumothorax increases cerebral blood flow velocity on Doppler ultrasound, and 
increases the incidence of intraventricular haemorrhage. (Hill, 1982; Mehrabani, 1991) 
The alterations in cerebral blood flow during the administration surfactant are of particular 
concern because surfactant administration is comparable to the intratracheal administration 
of perfluorocarbon when starting partial liquid ventilation. Any perfluorocarbon 
administration effects on cerebral blood flow may increase the risk of brain injury in the 
extremely preterm infant. 
4. Liquid ventilation 
Extremely preterm infants with immature lungs and severe lung disease could benefit 
greatly from alternative forms of respiratory support. New techniques are required because 
conventional forms of mechanical ventilation often don’t work (babies still die from their 
extremely immature lungs and lung disease) and often damage the lungs causing significant 
respiratory morbidity (lung injury and subsequent chronic lung disease). 
Liquid ventilation has been touted as an alternative form of respiratory support for 
numerous and varied types of lung disease. Extremely preterm infants with immature lungs 
and severe lung disease could benefit greatly from the technique of partial liquid 
ventilation. Recent studies have renewed the promise that partial liquid ventilation has 
significant potential to alter the course of neonatal lung disease and respiratory morbidity. 
(Blassnig, 2009) 
4.1 History 
Artificial respiration using liquid ventilation in mammals was initially tried in mice in the 
1960s with solutions of saline in a hyperbaric environment. (Kylstra, 1962) Later 
experiments in the 1960s showed the successful use of fluorocarbons at atmospheric 
pressure for liquid ventilation in mice and cats. (Clark, 1966) At first experiments with 
perfluorocarbons were performed with immersion in perfluorocarbon liquid with 
spontaneously breathing animals or with gravity-assist bulk tidal flow of perfluorocarbon 
liquid. These techniques were not successful at removing sufficient carbon dioxide. (Kylstra, 
1966; Schoenfish, 1973; Shaffer, 1978) Over the ensuing decades the use of time-cycled, 
pressure-limited mechanical ventilators allowed the development of the method of total 
liquid ventilation. (Shaffer, 1975) Total liquid ventilation can maintain adequate gas 
exchange in animals. (Wolfson, 1990)  It has also been shown to improve lung function and 
gas exchange in experimental animal models of respiratory distress. (Shaffer, 1976; Shaffer, 
1984; Shaffer, 1983; Wolfson, 1992) In 1991 Fuhrman et al. (Fuhrman, 1991) introduced the 
method of perfluorocarbon associated gas exchange using functional residual capacity 
volumes of perfluorocarbon with conventional gas ventilation. This technique is now best 
known as partial liquid ventilation and it is this technique which is most promising for 
practical clinical application. 
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4.2 Partial liquid ventilation 
The technique of partial liquid ventilation entails pouring perfluorocarbon liquid into the 
endotracheal tube whilst ventilating the lung with gas ventilation (either conventional or 
high-frequency) continues. Customarily the starting volume of perfluorocarbon instilled 
into the lungs equals the estimated functional residual capacity and the perfluorocarbon is 
usually given slowly over 10 to 20 minutes. Repeated doses of perfluorocarbon are then 
given at intervals to keep a fluid level in the endotracheal tube at a positive end expiratory 
pressure (PEEP) of zero. Repeat doses are necessary because the functional residual capacity 
will increase as the liquid recruits collapsed alveoli, and to replace losses due to 
evaporation. Stopping partial liquid ventilation is achieved by ceasing further instillation of 
perfluorocarbon to allow it to evaporate into the expired gases. The technique is the same 
when used with high-frequency ventilation. 
Perfluorocarbon liquids are a group of chemicals that are formed from the fluorination of 
organic compounds such as alkanes. They are odourless and colourless, and are chemically 
and biologically inert. Perfluorocarbons are almost insoluble in lipid and insoluble in water. 
They are more dense than water and soft tissue. Perfluorocarbon liquids can dissolve more 
than 20 times the oxygen, and three times the carbon dioxide, than water. They have a low 
surface tension and low viscosity, and most evaporate faster than water. (Shaffer, 1992; 
Degraeuwe, 1995) 
The physical characteristics of perfluorocarbon liquids (see Table 2) determine the effects of 
partial liquid ventilation (Figure 1). During normal breathing and gas ventilation the inert 
gas nitrogen carries oxygen and carbon dioxide. During liquid ventilation perfluorocarbon 
replaces nitrogen as the carrier of oxygen and carbon dioxide. Perfluorocarbon liquids have 
a high oxygen carrying capacity and high solubility for carbon dioxide. (Shaffer, 1992; 
Meaney, 1997) The perfluorocarbon liquid is oxygenated and carbon dioxide removed by 
means of bulk tidal flow of gas provided by the gas ventilator. This occurs for either 
conventional or high frequency ventilation. The movement of perfluorocarbon in small 
peripheral airways is facilitated by its low viscosity. 
The surface tension of perfluorocarbon liquids is low, (Shaffer, 1992) at around 15 to 18 
millinewton per metre (mN/m). When the perfluorocarbon liquids goes into the lung the 
air/liquid alveolar interface (which in surfactant deficiency has a high surface tension of up 
to 50 mN/m (von Bismarck, 2007)) is abolished and surface tension decreases. This increases 
compliance and therefore alveolar recruitment improves. This allows the use of lower 
ventilator pressures and smaller tidal volumes; with reduction of barotrauma and volu-
trauma respectively. Perfluorocarbons do not disturb natural surfactant production (Cleary, 
1997) and they do not wash surfactant out of the lungs. (Rüfer, 1970; Modell, 1970) 
Compared to water and soft tissue perfluorocarbon liquids have a high density (Shaffer, 
1992) and will therefore mechanically recruit collapsed alveoli. This happens preferentially 
in the dependant portions of the lung therefore decreasing intra-pulmonary shunting by 
improving ventilation/perfusion matching. (Kelly, 1997)  
Partial liquid ventilation has been known to have some anti-inflammatory effects. These 
were thought to be due mainly to the less injurious nature of liquid ventilation. However, it 
is now clear that perfluorocarbons have some direct anti-inflammatory action on cells (such 
as alveolar macrophages). Also this direct anti-inflammatory effect goes further than the  
perfluorocarbons acting as a simple barrier. (Heard, 2000) There is direct inhibition of the 
inflammatory response of alveolar macrophages in contact with perfluorocarbon liquids. 
(Smith, 1995; Thomassen, 1997) A recent study has shown that the disruption of lung 
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development in newborn rats, caused by hyperoxia, can be prevented by a single daily dose 
of perfluorocarbon liquid into the lungs.  (Blassnig, 2009) 
 
 
Fig. 1. The mechanical effects of partial liquid ventilation on respiratory function. (Davies, 
2011) (PaCO2 – arterial carbon dioxide; PaO2 – arterial oxygen; PBF – pulmonary blood flow; 
PFC – perfluorocarbon; PIP – peak inspiratory pressure; Q – perfusion; V –ventilation) 
4.3 Animal studies 
Partial liquid ventilation has been touted as an alternative form of respiratory support for 
many types of lung disease because it improves gas exchange and lung function in the 
diseased and injured lung. Many animal studies using various models of lung injury and 
surfactant lack have shown improvement in oxygenation, carbon dioxide clearance and lung 
compliance. (Foust, 1996; Tutuncu, 1993; Smith, 1997a; Leach, 1993; Leach, 1995; Curtis, 
1994a; Curtis, 1994b) Partial liquid ventilation is more effective in improving gas exchange 
and lung function than surfactant alone. (Leach, 1995) There is significantly less damage on 
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lung histology to lungs after partial liquid ventilation. (Foust, 1996; Smith, 1997a) Lower 
peak inspiratory pressures can be used to achieve adequate tidal volumes. (Degraeuwe, 
1996) Partial liquid ventilation decreases intra-pulmonary shunting. (Zobel, 1996) Partial 
liquid ventilation increases oxygenation when combined with nitric oxide when treating 
pulmonary hypertension. (Zobel, 1996) 
Most of the above studies have shown benefits of partial liquid ventilation over a few hours. 
Two studies have shown that it is feasible to use partial liquid ventilation for longer periods. 
Neonatal piglets with normal lungs have been ventilated for 24 hours with stable ventilation 
and blood gases with no haemodynamic deterioration. (Salman, 1995) Newborn piglets with 
surfactant deficiency demonstrated improved oxygenation and lung histology with up to 20 
hours of partial liquid ventilation. (Smith, 1997a) 
 
 Saline FC-77 Perflubron 
Density 
(g/mL)* 
1.0 1.78 1.93 
Kinematic viscosity 
(centistokes)* 
1.0 0.8 1.10 
Vapour pressure 
(mmHg)† 
47 85 11 
Surface tension 
(mN/m)* 
72 15 18 
Oxygen solubility 
(mL/100 mL)* 
3.0 50 53 
Carbon dioxide solubility 
(mL/100 mL) † 
57 198 210 
Table 2. Physical properties of two perfluorocarbon liquids compared with saline.  
(* 25°C; †37°C) 
Partial liquid ventilation has also been used with high frequency ventilation. Animal studies 
investigating the effects of partial liquid ventilation with high frequency ventilation have 
shown the combined technique provides good gas exchange. (Smith, 1997a; Baden, 1997, 
Mrozek, 1998; Smith, 1997b; Sukumar, 1998) Smith et al. (Smith, 1997b) comparing various 
methods of high frequency partial liquid ventilation, showed that those forms of high 
frequency ventilation which allow volume recruiting manoeuvres, such as the addition of 
intermittent conventional breaths, gave superior gas exchange. It seems that, with the use of 
strategies aimed at maximal alveolar recruitment, high frequency partial liquid ventilation 
may not confer any additional benefit over high frequency ventilation alone. Davies et al. 
(Davies, 1999) demonstrated that if maximal recruitment is obtained with high frequency 
ventilation prior to starting high frequency partial liquid ventilation that the addition of 
partial liquid ventilation did not further improve oxygenation.  
4.4 Human studies 
4.4.1 Adult 
A Cochrane systematic review (Davies, 2004a) of partial liquid ventilation in adults with 
acute lung injury and acute respiratory distress syndrome found one randomised, 
controlled trial. (Hirschl, 2002) Another randomised, controlled trial has since been 
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published. (Kacmarek, 2006) There were no differences, in either study, in any clinically 
relevant outcomes in patients ventilated with partial liquid ventilation compared with 
conventional ventilation. 
4.4.2 Paediatric  
The Cochrane systematic review (Davies, 2004b), updated in 2009, of partial liquid 
ventilation in children with acute lung injury and acute respiratory distress syndrome found 
only one randomised, controlled trial as yet unpublished. (Fuhrman, 1998) This trial abstract 
report showed results from a clinical trial that was stopped early on paediatric acute 
respiratory distress syndrome (ARDS). The protocol underwent a number of changes during 
the trial which resulted in three different sets of inclusion criteria. The final set, with 
liberalised inclusion criteria, had an unexpected decrease in mortality in the control group 
so the trial was stopped to allow full data analysis to determine the safety of partial liquid 
ventilation in this group of patients. There were 182 patients enrolled (less than 20% of the 
target numbers) with an overall mortality of 24/91 (26%) in the partial liquid ventilation 
group and 18/91 (20%) in the conventional mechanical ventilation group. The authors 
concluded that partial liquid ventilation with perflubron was safe, however the trial was not 
powered to detect real differences in mortality and ventilator free days. 
4.4.3 Neonatal  
There have been several published reports of uncontrolled studies on the use of partial 
liquid ventilation in human neonates. (Meaney, 1997; Greenspan, 1989; Hirschl, 1995; 
Pranikoff, 1996; Garver, 1996; Leach, 1996; Bruch, 1997) 
Pranikoff et al. (Pranikoff, 1996) reported the use of partial liquid ventilation in four infants 
with congenital diaphragmatic hernia, all of whom were on extra-corporeal life support at 
the time. There was improved oxygenation and total lung compliance with haemodynamic 
stability and no acute adverse effects. 
Leach et al. (Leach, 1996) reported the use of partial liquid ventilation in 13 preterm infants 
from 24–33 weeks gestational age who had severe respiratory distress syndrome and failing 
conventional therapy. Ten infants had from 24 to 72 hours of partial liquid ventilation with 
improvement in oxygenation and lung compliance. Six of the 10 survived to 36 weeks 
corrected age. The partial liquid ventilation reportedly well tolerated without significant 
haemodynamic disturbance. 
Two randomised controlled trials have been started in newborn infants but both were 
stopped before reaching their targeted numbers. Both remain unpublished. Hirschl wrote in 
a review on liquid ventilation of a randomised, controlled trial comparing conventional 
mechanical ventilation with partial liquid ventilation in preterm infants with severe lung 
disease. (Hirschl, 2004) Twenty-four patients were recruited to the study: 8 of 13 (62%) in the 
partial liquid ventilation group survived and all in the conventional ventilation group 
survived. Hirschl wrote that “This study was placed on hold concomitant with 
discontinuation of the paediatric trial and has not been resumed.” (Hirschl, 2004)  In another 
review Field wrote of a randomised, controlled trial where partial liquid ventilation was 
used in mature infants with respiratory failure; he wrote that “Twenty-four subjects were 
randomized before recruitment was unexpectedly and inexplicably suspended. The results 
have never been published.” (Field, 2002) 
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5. Perfluorocarbon liquid instillation and the effect on cerebral blood flow 
As discussed above one of the concerns with the use of partial liquid ventilation in 
extremely preterm infants is its possible effect on cerebral blood flow and the potential to 
cause brain injury, especially during the initial dosing of perfluorocarbon into the lungs at 
the start of partial liquid ventilation. It may well be that any of the benefits of partial liquid 
ventilation are outweighed by an increase in the risk of brain injury. 
Davies et al (Davies, 2010a; Davies, 2010b) studied the effects of perfluorocarbon dosing, 
when initiating partial liquid ventilation, on haemodynamics and cortical cerebral blood 
flow in preterm lambs. They showed that compared with preterm lambs continuing to be 
ventilated with conventional gas mechanical ventilation, lambs that received a dose of 
tracheal perfluorocarbon liquid at the start of partial liquid ventilation had an increase in 
their cortical cerebral blood flow. This could not be reasonably explained by any related 
changes in haemodynamics or oxygenation. The lambs that had 30 mL/kg of tracheal 
perfluorocarbon had a minimal increase in arterial carbon dioxide over the 30 minute 
observation period, although arterial carbon dioxide was not measured continuously and 
the difference was not statistically significant. Overall, three different loading doses of 
perfluorocarbon liquid were studied: 20, 30 and 40 mL/kg. (Davies, 2010a; Davies, 2010b) 
There were no significant haemodynamic changes during perfluorocarbon dosing in any of 
the three different doses in preterm lambs; and whilst the cortical cerebral blood flow was 
increased in all three groups there was no difference between groups. 
Davies (Davies, 2011) reported further studies in a rabbit model designed to investigate the 
effects of different dosing strategies on cerebral blood flow. These studies confirmed that 
when the dose of perfluorocarbon was given into the trachea at the start of partial liquid 
ventilation cerebral blood flow increased. The cerebral blood flow increased regardless of 
the volume of the dose of perfluorocarbon; either 10 or 20 mL/kg. Furthermore, if the 
arterial carbon dioxide was closely monitored and the ventilation adjusted to maintain 
target arterial carbon dioxide, or volume-controlled ventilation was used, then there was no 
increase in cerebral blood flow. There was no significant advantage in varying the duration 
of administration of the dose of perfluorocarbon within the range from 10 to 20 minutes, 
although it is probably best to avoid giving the dose over 5 minutes or less. There was no 
benefit in giving the dose of perfluorocarbon through a secondary lumen at the distal tip of 
the endotracheal tube. With differences in cerebral blood flow there were also differences in 
some of the variables that may explain these differences. There were no statistically 
significant differences seen in arterial carbon dioxide. Although, on the two occasions where 
the differences in arterial carbon dioxide were almost statistically significant there were 
significant differences in either carotid flow or cortical cerebral blood flow or both. On one 
of those occasions the differences in pH were statistically significant and the changes in 
arterial carbon dioxide mirrored changes in pH, as would be usual. There were associations 
between increasing cerebral blood flow (or its variability) and factors measured that might 
explain those increases. In those situations where cerebral blood flow were increased there 
were also consistent increases in blood pressure and arterial carbon dioxide, and decreases 
in arterial oxygen. The increases in arterial carbon dioxide were associated with decreases in 
tidal volumes delivered during perfluorocarbon dosing. The most compelling reason that it 
was simply decreased tidal volumes that caused increased arterial carbon dioxide was that 
during those dosing strategies where the tidal volumes did not decrease (when using 
volume-controlled ventilation or closely targeting arterial carbon dioxide by adjusting peak 
inspiratory pressure) the arterial carbon dioxide did not increase. 
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Burkhardt et al (Burkhardt, 2002) report the only other study that investigated the effects of 
perfluorocarbon dosing on surrogate measures of cerebral blood flow: cerebral 
concentration of total and oxygenated haemoglobin using near infrared spectroscopy. The 
cerebral concentration of oxygenated haemoglobin decreased initially (at 1 minute) when 30 
mL/kg was given extremely rapidly (over about 40 seconds), with return to baseline by 3 
min and an increase after 5 min. There was no decrease with 30 mL/kg given slowly (over 
about 16 minutes) nor when 10 mL/kg was administered. The cerebral concentration of 
oxygenated haemoglobin and the total cerebral haemoglobin concentration increased when 30 
mL/kg of perfluorocarbon was given but not with 10 mL/kg. Similarly in both 30 mL/kg 
groups the arterial carbon dioxide increased and arterial oxygen decreased but not in the 10 
mL/kg group. There was no control group, therefore conclusions cannot be drawn about the 
effect of perfluorocarbon dosing compared with gas ventilation alone. The study design makes 
direct comparisons between the two volumes of perfluorocarbon given difficult because the 
doses were also given over different durations. Interpretation is also difficult as they did not 
measure cerebral blood flow directly, did not record and report real-time haemodynamic 
variables during the perfluorocarbon liquid dosing, and only reported changes in cerebral 
oxygenation at discrete time points. Burkhardt et al (Burkhardt, 2002) concluded that giving 
perfluorocarbon extremely rapidly (20-30 times faster than the fastest dosing studied by 
Davies (Davies, 2011)) is not recommended because of the decrease in cerebral blood flow (as 
determined by total cerebral haemoglobin concentration) during perfluorocarbon dosing. 
From the results of the above studies we can surmise that perfluorocarbon should best be 
administered whilst either monitoring arterial carbon dioxide continuously during 
perfluorocarbon dosing and keeping it under tight control or using volume-controlled 
ventilation. This will prevent any decrease in arterial blood pressure or oxygenation, or any 
increase in arterial carbon dioxide. This in turn will prevent any disturbance of cerebral 
blood flow. The lowest possible dose-volume of perfluorocarbon should be used (e.g., 10 
mL/kg or smaller, larger volumes may be acceptable but shouldn’t be given too fast), and 
the dose should not be given over 5 minutes or less. 
Given the availability of a suitable product, randomised controlled trials of partial liquid 
ventilation in neonates are both feasible and desirable. Now the design of such trials can 
incorporate some of the data from the studies summarised above and ensure that the dosing 
procedure is as safe as it can be for use in extremely preterm infants. 
6. Conclusions 
As is demonstrated by the above studies partial liquid ventilation has great potential to 
disturb cerebral blood flow and increase the risk of brain injury. If partial liquid ventilation 
is to be used in extremely preterm infants it should be safe. The best protection for the 
extremely preterm brain is to start partial liquid ventilation safely without disturbing 
cerebral blood flow. Given the potential for harm associated with perfluorocarbon dosing in 
the most susceptible of preterm infants it is encouraging to know that there are ways of 
giving perfluorocarbon that can mitigate any increase in cerebral blood flow. 
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